Literature DB >> 7779774

Structure of the catalytic region of human complement protease C1s: study by chemical cross-linking and three-dimensional homology modeling.

V Rossi1, C Gaboriaud, M Lacroix, J Ulrich, J C Fontecilla-Camps, J Gagnon, G J Arlaud.   

Abstract

C1s is a multidomain serine protease that is responsible for the enzymatic activity of C1, the first component of the classical pathway of complement. Its catalytic region (gamma-B) comprises two contiguous complement control protein (CCP) modules, IV and V (about 60 residues each), a 15-residue intermediary segment, and the B chain (251 residues), which is the serine protease domain. With a view to identify domain-domain interactions within this region, the gamma-B fragment of C1s, obtained by limited proteolysis with plasmin, was chemically cross-linked with the water-soluble carbodiimide 1-ethyl-3-[3-(dimethylamino)propyl]carbodiimide; then cross-linked peptides were isolated after CNBr cleavage and thermolytic digestion. N-Terminal sequence and mass spectrometry analyses allowed us to identify two cross-links between Lys 405 of module V and Glu 672 of the B chain and between Glu 418 of the intermediary segment and Lys 608 of the B chain. Three-dimensional modeling of the CCP modules IV and V and of the catalytic B chain was also carried out on the basis of their respective homology with the 16th and 5th CCP modules of complement factor H and type I serine proteases. The information provided by both the chemical cross-linking studies and the homology modeling enabled us to construct a three-dimensional model for the assembly of the C-terminal part of the gamma-B region, comprising module V, the intermediary segment, and the B chain. This model shows that module V interacts with the serine protease B chain on the side opposite to both the activation site and the catalytic site. Functional implications of this interaction are discussed in terms of the possible role of module V in the specific recognition and positioning of C4, one of the two substrates of C1s.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7779774     DOI: 10.1021/bi00022a004

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  5 in total

Review 1.  Inhibition of complement as a therapeutic approach in inflammatory central nervous system (CNS) disease.

Authors:  S R Barnum
Journal:  Mol Med       Date:  1999-09       Impact factor: 6.354

2.  Trimeric reassembly of the globular domain of human C1q.

Authors:  Pascale Tacnet; Eric Chung Chee Cheong; Pierrette Goeltz; Berhane Ghebrehiwet; Gérard J Arlaud; Xiang-Yang Liu; Claire Lesieur
Journal:  Biochim Biophys Acta       Date:  2007-12-15

3.  Crystal structure of the catalytic domain of human complement c1s: a serine protease with a handle.

Authors:  C Gaboriaud; V Rossi; I Bally; G J Arlaud; J C Fontecilla-Camps
Journal:  EMBO J       Date:  2000-04-17       Impact factor: 11.598

4.  Chemical cross-linking with thiol-cleavable reagents combined with differential mass spectrometric peptide mapping--a novel approach to assess intermolecular protein contacts.

Authors:  K L Bennett; M Kussmann; P Björk; M Godzwon; M Mikkelsen; P Sørensen; P Roepstorff
Journal:  Protein Sci       Date:  2000-08       Impact factor: 6.725

5.  High throughput protein fold identification by using experimental constraints derived from intramolecular cross-links and mass spectrometry.

Authors:  M M Young; N Tang; J C Hempel; C M Oshiro; E W Taylor; I D Kuntz; B W Gibson; G Dollinger
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-23       Impact factor: 11.205

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.